title: Spinal and bulbar muscular atrophy: pathogenesis and clinical management.
abstract: Spinal and bulbar muscular atrophy, or Kennedy's disease, is an X-linked motor neuron disease caused by polyglutamine repeat expansion in the androgen receptor. The disease is characterised by weakness, atrophy and fasciculations in the limb and bulbar muscles. Affected males may have signs of androgen insensitivity, such as gynaecomastia and reduced fertility. Neurophysiological studies are typically consistent with diffuse denervation atrophy, and serum creatine kinase is usually elevated 2-5 times above normal. Progression of the disease is slow, and the focus of spinal and bulbar muscular atrophy (SBMA) management is to prevent complications.
authors: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
authors: C
authors: C
authors: Grunseich
authors: C
authors: C
authors: Rinaldi
authors: K H
authors: KH
authors: Fischbeck
mesh_terms: D006801:Humans; D020966:Muscular Disorders, Atrophic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
keywords: Kennedy's disease; craniofacial; genetics; motor neuron disease; spinal and bulbar muscular atrophy; weakness
references: Nature. 1991 Jul 4;352(6330):77-9
references: 2062380
references: Neuron. 2002 Aug 29;35(5):843-54
references: 12372280
references: Nature. 2004 Oct 14;431(7010):805-10
references: 15483602
references: Nat Med. 2003 Jun;9(6):768-73
references: 12754502
references: J Biol Chem. 2002 Dec 27;277(52):50855-9
references: 12388541
references: Ann Neurol. 1998 Aug;44(2):249-54
references: 9708548
references: Ann Neurol. 1992 Nov;32(5):707-10
references: 1449253
references: Clinics (Sao Paulo). 2011;66(6):955-7
references: 21808858
references: J Neurol Sci. 2008 Jan 15;264(1-2):100-5
references: 17854832
references: Ann Neurol. 2009 Feb;65(2):140-50
references: 19259967
references: J Neurol. 2001 Oct;248(10):856-60
references: 11697521
references: Neurology. 2002 Nov 12;59(9):1471-2
references: 12427914
references: Br J Dermatol. 2007 Aug;157(2):290-4
references: 17596176
references: Hum Mol Genet. 2004 Jun 1;13(11):1183-92
references: 15102712
references: Neuron. 2010 Sep 23;67(6):936-52
references: 20869592
references: Lancet Neurol. 2010 Sep;9(9):875-84
references: 20691641
references: Lancet Neurol. 2011 Feb;10(2):140-7
references: 21216197
references: Nat Rev Genet. 2005 Oct;6(10):743-55
references: 16205714
references: Muscle Nerve. 2009 Nov;40(5):809-14
references: 19670325
references: J Neurol Neurosurg Psychiatry. 1994 Oct;57(10):1274-5
references: 7931399
references: J Clin Invest. 2006 Oct;116(10):2663-72
references: 16981011
references: Annu Rev Neurosci. 2000;23:217-47
references: 10845064
references: Hum Mol Genet. 2000 Sep 1;9(14):2197-202
references: 10958659
references: Hum Mol Genet. 2002 Aug 15;11(17):1967-76
references: 12165558
references: Brain. 2006 Jun;129(Pt 6):1446-55
references: 16621916
references: Nat Chem Biol. 2011 Oct 30;7(12):925-34
references: 22037470
references: Hum Mol Genet. 2009 Jan 1;18(1):27-42
references: 18824496
references: J Neurol Sci. 1988 Nov;87(2-3):141-52
references: 3210030
references: Neurology. 2009 Jan 27;72(4):317-23
references: 19171827
references: Neurology. 1968 Jul;18(7):671-80
references: 4233749
references: J Neurol Sci. 1981 Jun;50(3):413-21
references: 7264705
references: J Neurosci. 2006 Nov 22;26(47):12106-17
references: 17122035
references: Brain. 2009 Dec;132(Pt 12):3242-51
references: 19846582
references: Nat Genet. 1992 Dec;2(4):301-4
references: 1303283